335 related articles for article (PubMed ID: 2626852)
21. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
Snady H; Lieber CS
Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727
[TBL] [Abstract][Full Text] [Related]
22. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
Ferenci P; Wewalka F
Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
[TBL] [Abstract][Full Text] [Related]
23. [Pilot study of the relationship of free amino acids in serum and in the cerebrospinal fluid of horses].
Grabner A; Goldberg M
Tierarztl Prax; 1991 Jun; 19(3):271-5. PubMed ID: 1887442
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of short-chain fatty acids in cirrhosis and hepatic coma.
Clausen MR; Mortensen PB; Bendtsen F
Hepatology; 1991 Dec; 14(6):1040-5. PubMed ID: 1959851
[TBL] [Abstract][Full Text] [Related]
26. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
Holecek M
Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
[TBL] [Abstract][Full Text] [Related]
27. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
[TBL] [Abstract][Full Text] [Related]
28. [Variations of the distribution of amino acids as a function of the outcome of hepatic lesions. Preliminary data].
Di Simone A; Riegler G; Stoppoloni G; Bernardi R
Med Chir Dig; 1978; 7(7):613-5. PubMed ID: 755149
[No Abstract] [Full Text] [Related]
29. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
31. [Differences in plasma aminograms in hepatic and diabetic coma].
Kleinberger G; Ferenci P; Gassner A; Pichler M; Lochs H
Z Gastroenterol; 1978 Dec; 16(12):752-9. PubMed ID: 741845
[TBL] [Abstract][Full Text] [Related]
32. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
Yoshida Y; Higashi T; Nouso K; Nakatsukasa H; Nakamura SI; Watanabe A; Tsuji T
Acta Med Okayama; 2001 Dec; 55(6):349-55. PubMed ID: 11779097
[TBL] [Abstract][Full Text] [Related]
33. Breath and blood ammonia in liver cirrhosis.
Shimamoto C; Hirata I; Katsu K
Hepatogastroenterology; 2000; 47(32):443-5. PubMed ID: 10791209
[TBL] [Abstract][Full Text] [Related]
34. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. II. Amino acids, free phenols and indoles.
Müting D; Perisoara A; Baum G; Flasshoff HJ; Bucsis L
Hepatogastroenterology; 1986 Apr; 33(2):66-70. PubMed ID: 3721389
[TBL] [Abstract][Full Text] [Related]
35. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
Schulte-Frohlinde E; Wagenpfeil S; Willis J; Lersch C; Eckel F; Schmid R; Schusdziarra V
J Gastroenterol Hepatol; 2007 Aug; 22(8):1241-8. PubMed ID: 17688664
[TBL] [Abstract][Full Text] [Related]
36. The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease.
McCullough AJ; Czaja AJ; Jones JD; Go VL
Gastroenterology; 1981 Oct; 81(4):645-52. PubMed ID: 7262510
[TBL] [Abstract][Full Text] [Related]
37. [Plasma amino acids in patients with liver cirrhosis treated with lactulose].
Giardina MG; Matarazzo M; Prantera T; Verre C; De Marco F
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2309-16. PubMed ID: 6529509
[TBL] [Abstract][Full Text] [Related]
38. Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.
Al Mardini H; Douglass A; Record C
Metab Brain Dis; 2006 Mar; 21(1):1-10. PubMed ID: 16773465
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
Therrien G; Rose C; Butterworth J; Butterworth RF
Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
[TBL] [Abstract][Full Text] [Related]
40. [Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
Szpakowicz T; Boroń P; Flisiak R; Bobrowska E; Kaczmarska A; Nowak HF; Zimnoch L
Przegl Lek; 1990; 47(7):527-31. PubMed ID: 2284419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
